338 related articles for article (PubMed ID: 23779105)
1. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
2. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Cheng YS; Sacchettini JC
Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
[TBL] [Abstract][Full Text] [Related]
3. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
4. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
5. The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives.
Agoni C; Ramharack P; Salifu EY; Soliman MES
Protein J; 2020 Apr; 39(2):106-117. PubMed ID: 32086691
[TBL] [Abstract][Full Text] [Related]
6. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
[TBL] [Abstract][Full Text] [Related]
7. Potency boost of a
Aragaw WW; Lee BM; Yang X; Zimmerman MD; Gengenbacher M; Dartois V; Chui WK; Jackson CJ; Dick T
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161270
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological validation of dihydrofolate reductase as a drug target in
Aragaw WW; Negatu DA; Bungard CJ; Dartois VA; Marrouni AE; Nickbarg EB; Olsen DB; Warrass R; Dick T
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0071723. PubMed ID: 38018963
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
11. Competition between H
Yu JF; Xu JT; Feng A; Qi BL; Gu J; Deng JY; Zhang XE
Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38275323
[TBL] [Abstract][Full Text] [Related]
12. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
[TBL] [Abstract][Full Text] [Related]
13. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
14. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
Suárez I; Roderus L; van Gumpel E; Jung N; Lehmann C; Fätkenheuer G; Hartmann P; Plum G; Rybniker J
Infection; 2017 Jun; 45(3):341-347. PubMed ID: 28303545
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase.
Masimirembwa CM; Phuong-dung N; Phuc BQ; Duc-Dao L; Sy ND; Sköld O; Swedberg G
Int J Antimicrob Agents; 1999 Aug; 12(3):203-11. PubMed ID: 10461838
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
19. E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim.
Raju A; Kulkarni S; Ray MK; Rajan MG; Degani MS
Int J Mycobacteriol; 2015 Jun; 4(2):97-103. PubMed ID: 26972877
[TBL] [Abstract][Full Text] [Related]
20. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]